Search Press releases Keywords From To 16 Oct 2021 Update on U.S. FDA Review of Biologics License Application (BLA) for bimekizumab Read More 8 Oct 2021 Disposals of own shares Read More 29 Sep 2021 New BIMZELX[®]▼ (bimekizumab) two-year data in moderate to severe plaque psoriasis presented at the 30th European Academy of Dermatology and Venereology (EADV) Congress Read More 24 Sep 2021 Disposals of own shares Read More 10 Sep 2021 Disposals of own shares Read More 6 Sep 2021 BIMZELX[®]▼ (bimekizumab) Receives First Positive Health Technology Assessment Worldwide Read More Pagination First page Previous page Previous … Page 40 Page 41 Page 42 Page 43 Current page 44 Page 45 Page 46 Page 47 Page 48 … Page 44 of 66 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
